Phase i study of neocarzinostatin in patients with acute leukemia
Van Echo, D.A.; Wiernik, P.H.
Cancer Treatment Reports 62(9): 1363-1365
1978
ISSN/ISBN: 0361-5960 PMID: 150945 Document Number: 138370
Document emailed within 1 workday
Related Documents
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Rivera, G.; Howarth, C.; Aur, R.J.; Pratt, C.B. 1978: Phase i study of neocarzinostatin in children with cancer Cancer Treatment Reports 62(12): 2105-2107
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005
Odajima, H.; Iwatake, K.; Baba, M.; Ode, S.; Kawai, H.; Matsui, T. 1988: A case of complete remission following recurrent relapses 12 years after onset of acute myelocytic leukemia. Response to protocol including neocarzinostatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 167-170
Marty, M.; Ferme, C.; Gisselbrecht, C.; Guy, H.; Clark, M.J.; Bancillon, A.; Boiron, M. 1985: Phase i study of bisantrene in acute nonlymphoblastic leukemia Cancer Treatment Reports 69(6): 703-705
Hines, J.D.; Mazza, J.J.; Oken, M.M.; Bennett, J.M.; Adelstein, D.J.; Keller, A.; O'Connell, M.J. 1985: High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase i Pilot Study for the Eastern Cooperative Oncology Group Seminars in Oncology 12(2 Suppl 3: 117-119
Omura, G.A.; Vogler, W.R.; Smalley, R.V.; Maldonado, N.; Broun, G.O.; Knospe, W.H.; Ahn, Y.S.; Faguet, G.B. 1977: Phase Ii Study of beta-2'-deoxythioguanosine in adult acute leukemia Cancer Treatment Reports 61(7): 1379-1381
Shalaev, V.A.; Gushcha, A.A. 1989: Clinical significance of the immunocompetence of patients with acute leukemia in the remission phase Gematologiia i Transfuziologiia 34(4): 27-30
Yamada, K.; Suzuki, H.; Kato, Y. 1980: Phase IIi study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(6): 1080-1085
Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1993: Early phase Ii study of Idarubicin, a new anthracycline anticancer drug, in acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 897-906
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Shiokawa, Y. 1987: Clinical study of the acute phase reaction. Acute phase proteins and a chronic inflammation, rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 45(5): 1068-1075
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Anderson, J.; Krivit, W.; Chilcote, R.; Pyesmany, A.; Chard, R.; Hammond, D. 1981: Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase IIi trial Cancer Treatment Reports 65(11-12): 1015-1019
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Souillet, G.; Philippe, N.; Manel, A.M.; Germain, D. 1979: Treatment of childhood acute lymphoblastic leukemia. Study of 171 patients. Value of pronostic factors for the differentiation and treatment of good and bad types. Study of 64 patients Pediatrie 34(5): 485-502